Archived: Rapid risk assessment: Hantavirus (Andes virus) outbreak on international cruise ship

Assessment completed: May 8, 2026 (based on information available up to May 7, 2026)

The situation with hantavirus (Andes virus) outbreak connected to the MV Hondius cruise ship is evolving. Please visit the Media update as of May 17, 2026 on Andes hantavirus situation for latest information on the event and Canada’s response.

The Public Health Agency of Canada is closely monitoring the situation and will review current evidence to reassess specific risk estimates and uncertainty. The overall risk of acquiring ANDV for the general population in connection with the ongoing cruise ship outbreak continues to remain low, in this situation, given that significant onward spread within Canada is not expected.

Canada will continue to implement appropriate public health protocols to prevent further spread from this outbreak. We are working very closely with our international and domestic partners from Provinces and Territories to inform our response and protect the health of Canadians.

On this page

Reason for the assessment

Canadian travellers have been identified as passengers on the MV Hondius cruise ship where there is an Andes virus (ANDV) outbreak and on flights carrying passengers infected with ANDV, a specific strain of hantavirus (see Event summary). This is the first documented ANDV outbreak in a cruise ship setting.Footnote 1 There is a need to identify and inform appropriate public health actions, including border measures, contact tracing, and risk communication. ANDV is not endemic to Canada and is epidemiologically distinct from the hantavirus strain endemic in Canada (the Sin Nombre virus).Footnote 2

Risk question

What is the likelihood and impact of a traveller infected with ANDV in connection with the MV Hondius cruise ship outbreakFootnote a entering Canada within the next two weeks?

Risk statement

The overall risk of acquiring ANDV for the general population in connection with the ongoing cruise ship outbreak is low (moderate uncertainty), given that onward spread within Canada is not expected, even if an infected individual were to arrive in Canada.

The likelihood of importation of ANDV into Canada in the next two weeks is moderate (moderate uncertainty). Six Canadians were on the vessel when it departed Argentina and four remain on board. Additionally, a few Canadians were on flights carrying symptomatic individuals and may have been in close contact with those infected. The impact on those infected is expected to be major (moderate uncertainty) as ANDV illness often requires hospitalization and can result in death. If importation into Canada was to occur, the impact of ANDV on the general population in Canada would be minor (low uncertainty), given that close, prolonged contact is required for person-to-person spread of ANDV, making onward spread unlikely. However, exposure is more likely for close contacts of cases and health care workers not using sufficient personal protective equipment (PPE).

These risk levels could change if evidence were to emerge suggesting that person-to-person transmission is occurring beyond close contacts.

Event summary (current situation as of May 7, 2026)

A cluster of Andes virus (ANDV) infections has been reported among passengers of the cruise ship MV Hondius. Eight cases have been reported, including three deaths and three hospitalizations. Five of the eight cases have been confirmed as hantavirus, and the other three are suspected. The MV Hondius was carrying 147 passengers and crew, 6 of whom were reported to be Canadian nationals. To date, all Canadians known to have been aboard the MV Hondius are asymptomatic. Canadians identified as vessel passengers (2), and a contact of a symptomatic individual on an aircraft (1) have returned home and have received guidance to self-quarantine and are being monitored by local authorities. Additionally, a confirmed case disembarked the MV Hondius and travelled from the island of St. Helena to Johannesburg, South Africa, via commercial airplane and then spent a short period on a flight bound for The Netherlands; 6 Canadians were on one or the other flight.

Considerations for pathogens with pandemic potential

At this time, ANDV is not considered to be a pathogen with pandemic potential. While person-to-person transmission of ANDV has been reported in the past, to date it has mainly been associated with close and prolonged contact and has not demonstrated the capacity for widespread prolonged transmission.Footnote 3 Additionally, there is evidence from in vivo passage studies that ANDV has high genomic stability and does not mutate easily.Footnote 4

Risk assessment details

Risk component: Estimate [Uncertainty] Rationale
Likelihood of importation into Canada: Moderate [Moderate]
  • Person-to-person transmission of ANDV has only been documented following prolonged close contact.Footnote 1Footnote 3 The environment on a cruise ship and aircrafts creates a unique situation of increased exposure risk to passengers and crew, due to crowding in confined spaces.
  • At this time, none of the remaining passengers on the MV Hondius are symptomatic, and operators of the ship have implemented a variety of infection prevention and control measures including disinfection of rooms and advising passengers to remain in their cabins where possible, wear medical masks when outside cabins, and practice maximal physical distancing. Medical assessment of all passengers and crew is being completed to assess individual risk of infection prior to disembarkation. Current containment measures, particularly rapid isolation of any new suspected cases, should limit the risk of further spread on the ship.
  • None of the cases to date are Canadian.
  • The three Canadians identified as MV Hondius passengers (2) or a contact of an infected individual (1) who have returned to Canada are currently asymptomatic, have been guided by their home jurisdictions to self-quarantine, and will continue to be monitored for any changes.
  • The incubation period of ANDV is between 1 and 8 weeks, with most individuals becoming symptomatic between 2-4 weeks after exposure.Footnote 3 It is possible that currently asymptomatic individuals may become infectious and develop symptoms during the risk assessment period.
  • The investigation is ongoing and there is engagement between the WHO, IHR focal points, and health authorities to share information and contact any individuals potentially exposed.

Impact on infected individuals:
Major [Moderate]

  • Clinical presentation following infection typically includes fever, headache, muscle aches and gastrointestinal symptoms such as abdominal pain, nausea or vomiting and may progress rapidly to cough, shortness of breath, accumulation of fluid in the lungs and shock with a case fatality rate (CFR) of up to 50%.Footnote 4 Clinical presentation may not be fully understood at this time due to lack of historic cases globally.
  • The current CFR of this outbreak is 37.5% (3/8 cases) with 3 individuals currently in hospital. Clinical presentation associated with this outbreak has been varied, with one individual exhibiting a mild fever and two individuals with mild respiratory and gastrointestinal symptoms.
  • There are no specific antiviral treatments, and early supportive care is critical. Ribavirin has been shown to improve outcomes for cases with haemorrhagic fever with renal syndrome.Footnote 5

Population level impact for population in Canada:
Minor [Low]

  • Given the close, prolonged contact required for person-to-person spread of ANDV, should an infected individual arrive in Canada, it is unlikely there will be onward spread.
  • In 2018-19, an outbreak of ANDV in Argentina (34 cases, 11 deaths) occurred due to person-to-person transmission following a single zoonotic exposure. Person-to-person transmission occurred primarily at social gatherings with prolonged, close contact.Footnote 3
  • High-risk contacts of infected individuals (e.g., spouses, healthcare workers without sufficient PPE) may be at elevated likelihood of being exposed. Notably, no nosocomial infections to healthcare workers occurred in the 2018 ANDV outbreak in Argentina.Footnote 3
  • Should an infected individual arrive, Canada has contact tracing, infection control, diagnostic,Footnote 6 and treatment protocols and capabilities, and appropriate PPE in healthcare settings. The rodent species that carries ANDV does not live in Canada, limiting the potential for ANDV to enter local animal populations and cause domestic zoonotic exposures.
  • There is the potential for indirect impacts associated with an importation, such as public anxiety and increased alarm from media coverage.

Limitations, knowledge gaps, and uncertainties

The overall uncertainty in this assessment is moderate, due to the following:

Factors that would decrease the risk include the ongoing assessments on board the ship and also planned by the Spanish authorities on arrival to Tenerife, implementation of sufficient infection control and public health measures including quarantine measures that effectively prevent onward spread on the ship, passengers following public health protocols as they disembark from the ship as well as en route home to Canada, followed by self-quarantine for the duration of the potential incubation period upon arrival in Canada.

Proposed actions

Reassessment

This situation is rapidly evolving. The risk assessment team will reconvene to review new evidence and evaluate the need for reassessment if there is new evidence changing our understanding of person-to-person transmission of ANDV or if the situation escalates.

Methods

This assessment was completed by the Public Health Agency of Canada. The rapid risk assessment (RRA) methodology is based on the World Health Organization (WHO) Member State RRA tool.Footnote 7 Likelihood, impact, and overall risk were estimated using previously described scales and risk matrix (see risk assessment methods page), and capacity to respond was estimated using the WHO tool.Footnote 7 The overall risk level for the general population was obtained using the overall population impact estimate, as it contains the driving component of risk for the general population, i.e., impact given that onward spread within Canada is not expected.

Footnotes

Footnote a

Within the context of this risk assessment, contacts linked to the ongoing MV Hondius outbreak include all passengers and crew aboard the ship upon departure from Ushuaia, Argentina, and any close contact of a passenger or crewmember of the ship thereafter (e.g., individuals exposed during air travel).

Return to footnote a referrer

References

Footnote 1

World Health Organization. WHO Media Library. 2026. Accessed May 7, 2026. https://who.canto.global/s/VUV00?viewIndex=0

Return to footnote 1 referrer

Footnote 2

National Collaborating Centre for Infectious Diseases. Hantavirus. August 11, 2021. Accessed May 7, 2026. https://nccid.ca/debrief/hantavirus/

Return to footnote 2 referrer

Footnote 3

Martínez VP, Di Paola N, Alonso DO, et al. "Super-Spreaders" and Person-to-Person Transmission of Andes Virus in Argentina. N Engl J Med. 2020;383(23):2230-2241. doi:10.1056/NEJMoa2009040

Return to footnote 3 referrer

Footnote 4

Warner BM, Prévost J, Tailor N, et al. High genomic stability of Andes virus following successive passage in vivo in Syrian hamsters. Schwemmle M, ed. J Virol. 2025;99(8):e00512-25. doi:10.1128/jvi.00512-25

Return to footnote 4 referrer

Footnote 5

Public Health Agency of Canada. For health professionals: Hantavirus infection. January 27, 2015. Accessed May 7, 2026. https://www.canada.ca/en/public-health/services/diseases/hantaviruses/health-professionals-treating-hantavirus-infection.html

Return to footnote 5 referrer

Footnote 6

Public Health Agency of Canada. Pathogen Safety Data Sheets: Infectious Substances – Hantavirus spp. August 19, 2011. Accessed May 7, 2026. https://www.canada.ca/en/public-health/services/laboratory-biosafety-biosecurity/pathogen-safety-data-sheets-risk-assessment/hantavirus.html

Return to footnote 6 referrer

Footnote 7

World Health Organization. User manual for the Member State Rapid Risk Assessment (MS-RRA) tool. February 25, 2026. Accessed May 7, 2026. https://www.who.int/southeastasia/internal-publications-detail/WHE2602262

Return to footnote 7 referrer

Page details

2026-06-03